Geneesmiddelenbeleid

This motion concerns the policy on medicines. It likely addresses issues related to the availability, affordability, and regulation of pharmaceutical products within the Netherlands. The motion may impact patients, healthcare providers, and the pharmaceutical industry, potentially leading to changes in drug pricing, access, or approval processes.